Comera Life Sciences Inc... (CMRAW)
NASDAQ: CMRAW
· Real-Time Price · USD
0.02
null (null%)
At close: Sep 17, 2024, 10:00 PM
Comera Life Sciences Cash Flow Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -9.01M | -9.93M | -17.61M | -18M | -17.07M | -14.9M | -7.8M | -5.45M | -3.43M | -2.51M | -533.4K |
Depreciation & Amortization | 99.86K | 100.66K | 97.43K | 93.95K | 94.39K | 89.76K | 88.58K | 86.14K | 61.93K | 42.77K | 22.33K |
Stock-Based Compensation | 996.1K | 856.23K | 634K | 375.79K | 269.03K | 175.63K | 1.14M | 1.11M | 1.07M | 1.04M | 13.88K |
Other Working Capital | 1.48M | 1.58M | 1.87M | 1.72M | 995.9K | 246.29K | -73.99K | -41.75K | -207.06K | n/a | n/a |
Other Non-Cash Items | -84.56K | 74.44K | 5.19M | 5.21M | 5.26M | 5.11M | 1.23M | 1.25M | 1.25M | 1.25M | 20.3K |
Deferred Income Tax | -72.59K | -72.59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.41M | 1.84M | 2.88M | 2.55M | 1.91M | 1.45M | 224.15K | 391.24K | 36.66K | 109.87K | 109.87K |
Operating Cash Flow | -6.66M | -7.14M | -8.81M | -9.77M | -9.53M | -8.07M | -6.14M | -3.76M | -2.15M | -1.22M | -490.78K |
Capital Expenditures | -28.68M | -28.7M | -28.7M | -28.61M | -159.16K | -145.47K | -142.01K | -142.01K | -11.46K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | 2.5K | 10.25K | 10.25K | 10.25K | 7.75K | n/a | n/a |
Other Investing Acitivies | 11.46K | 11.46K | 11.46K | 11.46K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -28.66M | -28.69M | -28.69M | -28.6M | -159.16K | -145.47K | -142.01K | -142.01K | -11.46K | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -453.21K | -208 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5.72M | 2.66M | 6.47M | 5.16M | 4.11M | 4.15M | 7.64M | 8.17M | 8.17M | 7.99M | 750K |
Financial Cash Flow | 5.85M | 2.79M | 6.6M | 5.24M | 4.11M | 6.26M | 9.75M | 10.28M | 10.28M | 7.99M | 750K |
Net Cash Flow | -901.48K | -4.46M | -2.32M | -4.56M | -5.57M | -1.96M | 3.47M | 6.38M | 8.11M | 6.77M | 259.22K |
Free Cash Flow | -35.34M | -35.84M | -37.51M | -38.38M | -9.69M | -8.22M | -6.28M | -3.9M | -2.17M | -1.22M | -490.78K |